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E-mail address: drjung@snu.ac.kr (G. Jung).The hepatitis B viral X protein (HBx) is a multifunctional protein that plays a role in the activation of
the NF-jB signaling pathway. In this study, we demonstrate that HBx up-regulates expression of
TANK-binding kinase-1 (TBK1) at the transcriptional level. Increased levels of TBK1 protein then
induce the phosphorylation of NF-jB p65 at serine 536. Because TBK1 is up-regulated by HBx as part
of its promotion of NF-jB activation, it is possible that increased TBK1 levels play a role in the devel-
opment of hepatocellular carcinoma (HCC). From these data, we suggest that TBK1 may play a role in
the HBx-mediated activation of the NF-jB signaling pathway and the development of HCCs.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction among the kinases that mediate the inducible phosphorylation ofHepatitis B virus (HBV) is the major worldwide etiologic factor
of chronic liver diseases, including chronic hepatitis, liver cirrhosis
and hepatocellular carcinoma (HCC), especially in Asia and Africa
[1]. One of the pathogenic mechanisms associated with HBV infec-
tion is the activation of the NF-jB signaling pathway, a key regula-
tor of cancer development.
The HBV genome encodes four genes, HBc, HBs, HBV pol and
HBx [2]. Our group and several others have reported that HBV
and HBx [3–6] can activate NF-jB in liver cells. This ﬁnding corre-
lates with studies that have reported that HBx plays a variety of
roles in host cells, which includes a role as a promiscuous transac-
tivator that is involved in cell growth [7] and cell death [8] in HCC.
Recently, TANK-binding kinase-1 (TBK1) was found to be struc-
turally similar to the classical IKKa, b kinases [9]. TBK1 is a key
component in the development of the IFN-mediated antiviral re-
sponse. For example, TBK1 phosphorylates transcription factors
such as IFN regulatory factor (IRF)-3 [10] and IRF-7 [11], leading
to the activation of the IFNab gene. Furthermore, recent studies
have shown that TBK1 is involved in NF-jB activation. TBK1 ischemical Societies. Published by E
itis B viral X protein; NF-jB,
nase-1; HCC, hepatocellular
f Biological Sciences, College
8 Daehak-dong, Gwanak-gu,p65 at Ser-536, an event that is proposed to stimulate inherent
p65 transactivation and thus NF-jB signaling [12].
In this study, we demonstrate that TBK1 is expressed strongly in
liver cancer cells and that it is involved in regulating HBx-mediated
NF-jB activity by controlling basal/constitutive p65/RelA phos-
phorylation at Ser-536, a modiﬁcation that is proposed to contrib-
ute to the transactivation of NF-jB. These data indicate a role for
TBK1 in controlling proliferation of certain liver cancer cells
through the regulation of constitutive HBx-mediated NF-jB
activity.
2. Materials and methods (see Supplementary data)
2.1. Plasmids
The wild-type TBK1 expression plasmid was a kind gift from
Kate Fitzgerald (University of Massachusetts Medical School). The
TBK1 K38A mutant was cloned by PCR-based mutagenesis. TBK1
KD was cloned into the eukaryotic expression vector p3XFlag-
CMV7.1 (Sigma, St. Louis, MO). For other plasmids, see Supplemen-
tary data.
2.2. Cell culture
To establish Huh7 lines stably expressing HBx, we inserted the
HBx complementary DNA sequence (HBV adr type) into the
pRcCMV (Invitrogen, Carlsbad, CA) vector and transfected thelsevier B.V. All rights reserved.
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HA-HBx (Huh7-HBx) by using Fugene6 (Roche, Penzberg,
Germany). G418 (Invitrogen, Carlsbad, CA) was used to select col-
onies. For other cell lines, see Supplementary data.3. Results
3.1. Establishment of a cell line that stably expresses HBx
In order to identify new factors involved in the HBx-mediated
NF-jB signaling pathway, we established human hepatoma cell
lines that stably express HBx protein (Huh7_HBx) and control cells
(Huh7_cont), which only contain the empty expression vector. In
our cell lines, stable expression of HBx transcript was conﬁrmed
by RT-PCR analysis (Fig. 1a). We also conﬁrmed that Huh7_HBx cell
lines were capable of activating the NF-jB pathway by detecting a
signiﬁcant increase in IjBa degradation (Fig. 1b) and observing in-
creased NF-jB2 (p52) expression (Fig. 1c). Using an NF-jB phos-
pho-speciﬁc antibody microarray, we showed higher levels of
phosphorylation of p65 Ser-468 and Ser-536 in Huh7_HBx cell
lines compared to Huh7_cont cell lines (Fig. 1d). We were also able
to observe similar phosphorylation of p65 Ser-536 by western blot
analysis (Fig. 1e). Therefore, these results suggest that the NF-jB
pathway was activated in our HBx-expressing cell line.
3.2. HBx-induced elevation of TBK1 expression causes NF-jB
activation
As a preliminary step towards investigating how HBx activates
the NF-jB pathway, we used a Human NF-jB Signaling Pathway
RT2Proﬁler™ PCR Array (SABiosciences Corporation) to compare
transcript levels in the control and HBx-expressing cell lines. Using
this array, we were able to observe the transcript levels of 84 genes
involved in the NF-jB pathway (see Supplementary Table 1).
Based on differences in expression, we chose 12 of the most
highly up-regulated genes for further examination by real-time
RT-PCR (Fig. 2a). One of the more interesting candidates wasFig. 1. Examination of NF-jB activity in a cell line stably expressing HBx. (a) Expression o
synthesized by priming with oligo dTs. DNA fragments encoding HBx and b-actin were a
gel. (b) Endogenous levels of IjBa protein in Huh7_cont and Huh7_HBx cells were de
analyses of NF-jB2 (p52), (p100) and b-actin levels in Huh7_cont and Huh7_HBx cells. Im
(d) Phosphorylation of p65 at Ser-468 and Ser-536 was analyzed using a NF-jB phospho-s
actin were analyzed by immunoblot using antibodies against p65 phosphorylated at SeTBK1 because this protein plays a direct role in activating NF-jB
by phosphorylating IjB, which allows NF-jB to translocate to the
nucleus. Real-time RT-PCR conﬁrmed that TBK1 transcript levels
were 5.7 times higher in the HBx cell line than in the control. Fur-
thermore, we were able to observe a similar up-regulation of TBK1
protein levels using western blot analysis (Fig. 2b). In immunopre-
cipitation experiments, we did not observe any evidence for an
interaction between HBx and TBK1 (data not shown), further dem-
onstrating that the increase in TBK1 protein was due to increased
transcription that was mediated by HBx. To determine if HBx reg-
ulated the expression levels of other IKK-related kinases in our sys-
tem, we examined the expression levels of IKKa and IKKe by
western blot analysis (Fig. 2b).
Interestingly, we found that IKKa was up-regulated while IKKe
was down-regulated. It is currently unknown how IKKe affects
HBx-mediated NF-jB activation. However, IKKa has been previ-
ously reported to play a role in HBV-mediated NF-jB activation
[13] and we were able to conﬁrm an increase in IKKa kinase activ-
ity in Huh7_HBx cells (Fig. 2c).
Taken together, these results indicate that our HBx cell line is a
valid model for studying HBx-mediated NF-jB activation and that
TBK1 may mediate HBx up-regulation of the NF-jB pathway.
To determine whether TBK1 might play a role in the phosphor-
ylation of p65 Ser-536, we performed a TBK1 knockdown experi-
ment using TBK1 shRNA. Following transfection of Huh7_ cont
and Huh7_HBx cells with TBK1 shRNA, we observed a decreased le-
vel of expression of phosphorylated p65 Ser-536 (Fig. 2d). How-
ever, no changes in expression of IKKe and IKKa were detected,
which suggests that the down-regulation of phosphorylated p65
was related speciﬁcally to the down-regulation of TBK1. Thus, we
have been able to show that both TBK1 mRNA and protein levels
are up-regulated in our Huh7_HBx cell line and that TBK1 levels
are closely linked to phosphorylation of NF-jB p65 at Ser-536.
3.3. TBK1 is involved in the HBx-mediated NF-jB pathway
Next, we examined whether TBK1 plays a role in HBx-mediated
activation of the NF-jB pathway. We transiently transfected sev-f the HBx transcript was assessed by RT-PCR. Total RNA was extracted and cDNA was
mpliﬁed with gene-speciﬁc primers and PCR products were resolved on an agarose
termined by immunoblot. b-Actin was used as a loading control. (c) Immunoblot
munoblots were performed using speciﬁc antibodies against the proteins indicated.
peciﬁc antibody microarray. (e) Levels of p65 phosphorylated at Ser-536, p65 and b-
r-536, p65 and b-actin.
Fig. 2. Identiﬁcation of TBK1 in Huh7_cont and Huh7_HBx cell lines. (a) Real-time RT-PCR analysis was performed to determine the levels CASP8, F2R, TBK1, IKKa, MAP3K1,
TRADD, TRAF2, TLR2, EDG2, CASP1, IKKe and GJA1, in Huh7_cont and Huh7_HBx cells. All numerical data represent the mean and standard deviation of three independent
experiments. (b) Expression of TBK1, IKKe, IKKa and b-actin, in Huh7_cont and Huh7_HBx cells. Immunoblot analysis was performed with anti-TBK1, IKKe, IKKa and b-actin
antibodies. (c) Huh7_cont and Huh7_HBx cell lysates were immunoprecipitated with antibody against IKKa. One set of immunoprecipitates was subjected to the kinase assay
(KA), which uses GST-IjBa (Coomassie stain) as a substrate. The other set of immunoprecipitates was subjected to 7.5% SDS–PAGE and analyzed by immunoblotting (IB) with
the anti-IKKa Ab. The abundance of immunoprecipitated kinase complex was conﬁrmed by immunoblotting against IKKa. (d) Huh7_cont and Huh7_HBx cells were
transfected with control and TBK1 shRNA and subjected to puromycin selection. The expression of TBK1, p65 Ser-536, IKKe, IKKa and b-actin, in Huh7_cont and Huh7_HBx
cells, was examined by immunoblot analysis with anti-TBK1, p65 Ser-536, IKKe, IKKa and b-actin antibodies.
H.R. Kim et al. / FEBS Letters 584 (2010) 525–530 527eral human hepatoma (Huh7 and Hep3B) and human embryo kid-
ney (HEK293 and HEK293T) cell lines with a mammalian overex-
pression plasmid containing TBK1 cDNA. Using a luciferase
reporter assay to detect transcription of NF-jB, we found that
overexpression of TBK1 increased NF-jB activity to different levels
in all cell lines (Fig. 3a).
To establish a relationship between HBx and TBK1 in the activa-
tion of NF-jB, we constructed two TBK1 mutants; TBK1 KD, in
which the TBK1 kinase domain was deleted and TBK1 K38A, the
point mutant. Both mutants have been previously reported to be
dominant negative forms that inhibit the activity of wild-type
TBK1 [9]. Using the luciferase reporter assay, we observed that
co-transfection of cells with vectors overexpressing TBK1 and HBx
synergized a further increase in NF-jB activity, compared to TBK1
or HBx expression alone. However, both TBK1 KD and TBK1 K38A
inhibited HBx-mediated NF-jB activation in HEK293 cells (Fig. 3b).
Many previous studies have shown that HBx activates NF-jB by
two- to ﬁvefold [13,14]. In this study, HBx increases NF-jB activity
by 2.4-fold in HEK293 cells (Fig. 3b).
Furthermore, the TBK1 K38A mutant inhibited HBx-mediated
phosphorylation of p65 at Ser-536 in HEK293T cells (Fig. 3c).
We also performed immunoﬂuorescence analyses to determine
if the expression of HBx or TBK1 could induce nuclear translocation
of p65, an important step that must occur before p65 can bind
DNA. We transiently transfected HEK293T cells with Myc-p65,
HA-HBx, Flag-TBK1 and Flag-TBK1 K38A. Overexpression of HA-HBx and Flag-TBK1 resulted in the translocation of the p65 subunit
of NF-jB (Myc-p65) into the nucleus, whereas it localized to the
cytoplasm with overexpression of the dominant negative mutant
Flag-TBK1 K38A (Fig. 3d).
Previous reports have shown that TBK1-mediated NF-jB activa-
tion can be blocked by dominant negative (DN) versions of NIK,
IKKa and IKKb [9]. Therefore, we used the luciferase assay to deter-
mine whether IKKa DN or NIK DN could inhibit reporter stimula-
tion when TBK1 is overexpressed. We found that both DN
mutants were capable of inhibiting TBK1-mediated NF-jB activa-
tion in HEK293 cells (Fig. 3e).
Activation of the NF-jB gene program requires DNA-binding by
Rel family proteins. Previously, TBK1 was reported to induce
p50:p65 DNA-binding activity in HEK293 cells [9]. Supershift
EMSA was used to explore the HBx-mediated increase in NF-jB
DNA-binding activity in the Huh7_HBx cell line. Only NF-jB p65
could be identiﬁed in the NF-jB-DNA complex induced by HBx
and TBK1 (Fig. 3f).
Our data suggest that in the Huh7_HBx cell line, the up-regula-
tion of TBK1 is able to promote NF-jB activation.
3.4. TBK1 expression level increases in cancer cell lines and tumor
tissue samples
A positive correlation between NF-jB activation and the pro-
gression of cancer has been widely reported. Based on our observa-
Fig. 3. Analysis of NF-jB activation by HBx and TBK1. NF-jB activation was analyzed by a luciferase reporter assay. All cells were co-transfected with 0.25 lg pNF-jB-Luc
reporter plasmid and 0.05 lg pRL-SV40. Additional expression vectors were transfected as indicated. (a) Following transfection of Huh7, Hep3B, HEK293 and HEK293T cells
with 0.5 lg pCDNA3-Flag/TBK1 (TBK1 expression plasmid), luciferase activities were estimated. (b) HEK293 cells were co-transfected with 0.5 lg pRcCMV/HA-HBx and
0.5 lg p3XFlag-CMV/TBK1, p3XFlag-CMV/TBK1 K38A or p3xFlag-CMV/TBK1 KD. The luciferase assay was performed 48 h after transfection. (c) HEK293T cells were co-
transfected with pCMV-myc/p65 and different combinations of p3XFlag-CMV/TBK1 or p3XFlag-CMV/TBK1 K38A and pRcCMV/HA-HBx. With the exception of pCMV-myc/
p65, all of the other plasmids have the SV40 ori. After 48 h, cell lysates were prepared and immunoprecipitated using the anti-myc antibody. Phosphorylation of NF-jB p65 at
the Ser-536 residue and expression of TBK1, TBK1 K38A, HBx and p65, were tested by immunoblot analysis with anti-phospho p65 Ser-536, Flag, HA and Myc antibodies. (d)
HEK293T cells were co-transfected with pCMV-myc/p65 (Myc-p65) and p3XFlag-CMV/TBK1 (Flag-TBK1) or p3XFlag-CMV/TBK1 K38A (Flag-TBK1*) and pRcCMV/HA-HBx
(HA-HBx). After 24 h, cellular localization of p65 (green), HBx (red), TBK1 (red) and TBK1 mutant (red) were examined. Scale bar, 50 lm. (e) HEK293 cells were co-transfected
with various combinations of 0.5 lg pRcCMV/HA-HBx, p3XFlag-CMV/TBK1, pFlag-IKKa, pFlag-IKKa DN and pFlag-NIK DN. After 48 h, luciferase assays were performed. (f)
EMSA analysis of the effect of HBx-mediated NF-jB activation in Huh7_cont and Huh7_HBx cells. Supershift analysis of NF-jB/NF-jB probe complexes using anti-p50, p52,
p65 and RelB antibodies (Ab), as described in Materials and Methods. Data represent the mean ± standard error of the mean. *P < 0.05.
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tulated that cancer cells and tumor tissues would exhibit elevated
TBK1 protein levels. We performed western blot analyses to mea-
sure the concentration of TBK1 in human hepatoma (Huh7, Hep3B,
HepG2, HLE, PLC, SNU387 and SNU475), Chang liver and human
embryo kidney (HEK293T) cell lines. We discovered signiﬁcantly
higher TBK1 levels in human hepatoma cell lines (Hep3B, HepG2,
HLE, PLC, SNU387 and SNU475) than in Chang liver and HEK293T
cell lines (Fig. 4a).
Because NF-jB activity is known to promote proliferation [15],
knockdown of TBK1 may decrease cell viability. We found that
TBK1 shRNA knockdown of TBK1 levels down-regulated cell prolif-
eration more in Huh7_HBx cells than in Huh7_cont cells (Fig. 4b).
Also, we conﬁrmed that TBK1 shRNA knockdown of TBK1 levels
down-regulated cell proliferation in Hep3B cells (Fig. 4c).
As chronic infection with HBV is closely linked to HCC, we
tested to see if HBV-positive serum from HCC tissue samples had
increased levels of TBK1. Immunoblot analysis of TBK1 levels was
performed on 75 human HCC tissue samples. A signiﬁcant increase
in TBK1 expression was observed in tumor versus non-tumor tis-Fig. 4. TBK1 is up-regulated in HCC. (a) Expression of TBK1 and b-actin in Huh7, Hep3B,
was performed using anti-TBK1 or b-actin antibodies. (b) Huh7_cont and Huh7_HBx c
determined using a CCK-8 assay. (c) Hep3B cells were co-transfected with various combi
determined using a CCK-8 assay. The expression of TBK1, HBx and b-actin in Hep3B cells
(d) TBK1 and b-actin levels in HCC tissues. Immunoblot analysis was performed using anti
(e) The extent of increase in TBK1 level correlated with histological grade. P value, Speasues. The relationship between expression of TBK1 and HCC grade
was analyzed by calculating the Spearman correlation and a P va-
lue of 0.036 was considered statistically signiﬁcant. Analysis re-
vealed a strong correlation between increased TBK1 expression
and grade 3 HCC (Fig. 4d and e and see Supplementary Table 2).
4. Discussion
In this study, we proposed that HBx activate NF-jB signaling
through the up-regulation of TBK1. We demonstrated that HBx
may up-regulate the expression of TBK1 at the transcriptional level
by examining HBx-expressing cell lines using a Human NF-jB Sig-
naling Pathway PCR Array, real-time RT-PCR analysis and western
blot analyses (Fig. 2a and b and see Supplementary Table 1). We
also observed that TBK1 may be responsible for HBx-mediated
NF-jB activation by using dominant negative forms of TBK1. Spe-
ciﬁcally, these mutants inhibited HBx-mediated NF-jB-dependent
promoter activity (Fig. 3b), as well as phosphorylation of NF-jB
p65 at Ser-536 (Fig. 3c). Furthermore, we found elevated TBK1
expression levels in cancer cell lines and HBV-positive humanHepG2, HLE, PLC, SNU387, SNU475, Chang and HEK293T cells. Immunoblot analysis
ells were transfected with cont shRNA or TBK1 shRNA and then cell viability was
nations of pRcCMV/HA-HBx, cont shRNA or TBK1 shRNA and then cell viability was
, was examined by immunoblot analysis with anti-TBK1, HA and b-actin antibodies.
-TBK1 or b-actin antibodies. T, tumor; N, non-tumor; G, Edmondson–Steiner’s grade.
rman correlation.*, Value was statistically signiﬁcant. N, number of cases.
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that HBx-mediated regulation of TBK1 occurred in both our HBx-
expressing cell system and in patient tissues (Fig. 4). Thus, TBK1
may play a role in regulating the HBx-mediated NF-jB pathway
during the development of hepatocellular carcinoma.
Previous reports have identiﬁed various mechanisms by which
HBx is able to mediate NF-jB activity. Previously, we found that
HBx was able to up-regulate the expression of Cyclin D1 via the
NF-jB-binding site in the Cyclin D1 promoter. In that report, we
also proposed that HBx was able to up-regulate BCL-3, which forms
a complex with p52 to activate the transcription of Cyclin D1 [16].
Our RT-PCR array analysis detected an increase in BCL-3 in the
HBx-expressing cell line, which conﬁrms the ﬁndings in our previ-
ous report. However, we were able to identify a much greater in-
crease in TBK1 levels, which prompted our selection of TBK1 as
the focus for this study. As a multifunctional protein that is capable
of activating several key signaling pathways, it is not too surprising
that HBx is able to activate NF-jB through different pathways. The
fact that HBx has the ability to regulate several genes that may in
turn activate NF-jB signaling highlights its importance in NF-jB
activation.
However, there were some differences between our ﬁndings
and previous reports, speciﬁcally in regard to TNFa [17] and inter-
ferons, which are key proteins in NF-jB signaling. One reason for
these discrepancies may be the use of different cell systems. To ob-
serve up-regulation of TNFa, Pezzi et al. performed a transient
transfection of HBx into HepG2 cells. In this report, we used a sta-
ble cell line derived from Huh7 cells. Furthermore, differences in
gene regulation may have resulted from growth selection in our
HBx cell line.
The role of IKKe in NF-jB activation has not been fully eluci-
dated. In a previous study, it was reported that IKKe-/- cells show
unchanged inducible IjBa phosphorylation [18]. Therefore, HBx/
TBK1 activation of NF-jB might be independent of IKKe.
In this report we have shown that HBx-mediated up-regulation
of TBK1 expression may contribute to HBx activation of NF-jB. We
also found a positive correlation between the expression level of
TBK1 and hepatocellular carcinoma. Therefore, we propose that
HBx regulation of TBK1 may induce the development of hepatocel-
lular carcinoma that is observed in the HBV-positive population.
Our ﬁndings may suggest new therapeutic approaches for curing
hepatocellular carcinoma by targeting TBK1.
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